AMDL, Inc.
CA-125 test has higher levels of sensitivity and specificity when run with DR-70
Published in Elder Law Weekly, September 14th, 2005
AMDL, Inc., (ADL), developer and marketer of tests for the early detection of cancer and other serious diseases, reported that German researchers at the department of gynecology and gynecological oncology at the University of Mainz, Germany, concluded in an abstract that AMDL's DR-70 test has both higher levels of sensitivity and specificity when the test is run simultaneously with CA-125, a tumor marker for the detection of ovarian carcinoma, than when CA-125 is run alone.
The researchers collected blood from 100 apparently healthy females and 61 ovarian cancer patients. The cut off level for DR-70 was set at 1.2 mcg/ml. The specificity of DR-70 at this level was 100%...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
Source: Elder Law Weekly (2005-09-14)
More Articles from Elder Law Weekly
- Alzheimer's Association
Alzheimer group names Harry Johns president and CEO - Institute of Clinical Physiology, Italy
Cancer risk from hormone replacement therapy examined - Merz Pharmaceuticals
Alzheimer substance memantine strengthens company's market position - Univ. of California, San Diego
Alpha-synuclein shows promise against Lewy body disease - AgResearch
Researchers detail new studies and findings in the area of tuberculosis vaccines - Alfred Hospital, Prahran
Ischemic injury studied, effects on chronic damage in renal grafts revealed - More from this issue of Elder Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
